UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049624
Receipt number R000056510
Scientific Title Blood-brain barrier function assessed with MRI in cognitive deficits in neurological disorders
Date of disclosure of the study information 2023/01/01
Last modified on 2023/07/28 10:49:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Blood-brain barrier function assessed with MRI in cognitive deficits in neurological disorders

Acronym

Blood-brain barrier function assessed with MRI in cognitive deficits in neurological disorders

Scientific Title

Blood-brain barrier function assessed with MRI in cognitive deficits in neurological disorders

Scientific Title:Acronym

Blood-brain barrier function assessed with MRI in cognitive deficits in neurological disorders

Region

Japan


Condition

Condition

Alzheimer disease, Dementia with Lewy bodies, Parkinson disease, Parkinsonism related disorders

Classification by specialty

Neurology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify whether blood-brain barrier dysfunction contributes to cognitive deficits in neurodegenerative diseases

Basic objectives2

Others

Basic objectives -Others

To clarify whether blood-brain barrier dysfunction contributes to cognitive deficits in neurodegenerative diseases

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

blood-brain barrier function

Key secondary outcomes

Evaluation of cognitive function


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Medicine Device,equipment

Interventions/Control_1

dynamic contrast-enhanced magnetic resonance imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with Alzheimer disease, Dementia with Lewy bodies, Parkinson disease and Parkinsonism related disorders. Healthy volunteers.

Key exclusion criteria

Chronic and acute renal failure with eGFR less than 30 ml/min/1.73m2

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Nobukatsu
Middle name
Last name Sawamoto

Organization

Kyoto University Hospital

Division name

Department of Neurology

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507

TEL

075-751-3771

Email

neuroofc@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Nobukatsu
Middle name
Last name Sawamoto

Organization

Kyoto University Hospital

Division name

Department of Neurology

Zip code

606-8507

Address

54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507

TEL

075-751-3771

Homepage URL


Email

neuroofc@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Hospital

Institute

Department

Personal name



Funding Source

Organization

JSPS

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto University Graduate School and Faculty of Medicine, Ethics Committee

Address

Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, JAPAN

Tel

075-753-4680

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 12 Month 10 Day

Date of IRB

2023 Year 02 Month 27 Day

Anticipated trial start date

2023 Year 02 Month 27 Day

Last follow-up date

2033 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

intervention study with minor invasion


Management information

Registered date

2022 Year 11 Month 27 Day

Last modified on

2023 Year 07 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056510


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name